Trachoma control using the who adopted "safe with azithromycin"

East African Medical Journal

Volumn 84, Issue 3, 2007, Pages 127-135

  Karimurio, J ^a   Ilako, F ^b   Gichangi, M ^c  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b AMREF HEALTH AFRICA   (Kenya)

^c MINISTRY OF HEALTH   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN;

ADOLESCENT; ARTICLE; CHILD; FEMALE; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; INFANT; KENYA; MALE; PILOT STUDY; PRESCHOOL CHILD; TRACHOMA; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH PROMOTION; HEALTH SURVEYS; HUMANS; INFANT; KENYA; MALE; PILOT PROJECTS; TRACHOMA; WORLD HEALTH ORGANIZATION;

EID: 34447564237     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Karimurio J., Gichangi M., Ilako D., Kilima P. and Adala H. Prevalence of trachoma in six districts of Kenya. East Afr. Med. J. 2006; 83: 63-68.
2. Gordon J., MinassianD. and Weale R. The epidemiology of Eye Disease. Chapman and Hall, London (1998).
3. Whitfield R., Schwab L., Ross-Degnan D., Steinkuller P. and Swartwood J. Blindness and eye disease in Kenya: Ocular status survey results from the Kenya rural blindness prevention project. Brit. J. Ophthalmol. 1990; 74: 333-340.
4. Dan P.E., Gillian V.H. and Christine C.F. An evaluation of a SAFE-style trachoma control program in Central Australia. Med.J.Australia. 2003; 178: 65-68.
5. Matende I., Kollman M., Karimurio J. and Gaeckle M. The prevalence and pattern of trachoma in Shompolelocation, Magadi Division of Kajiado District, Kenya. Department of Ophthalmology; University of Nairobi postgraduate thesis (2003) (Not published).
6. WHO. Primary health care level management of trachoma 1993; WHO/PBL/93.33.
7. International trachoma initiative standardised protocol for baseline prevalence survey for trachoma.
8. WHO. Achieving community support for Trachoma control: A guide for district health workers 1993; WHO/PBL/93.6.
9. WHO. Primary health care level management of trachoma 1933; WHO/PBL/93.33.
10. Bruce G., Yinghui M., Vicky C., et al. Eradication may not be too high a goal for trachoma programs. Emerging Infect. Dis. 2003; 9:596-598.
11. Solomon A., Holland M., Alexander N., Massae P., et al. Mass treatment with single dose azithromycin for trachoma. N. Engl. J. Med. 2004; 351:1962-1971.
12. Edwards T., Cumberland P., Hailu G. and Todd J. Can health education messages alleviate active trachoma in hyperendemic rural communities? Ophthalmol. 2006; 113:548-555.
13. West S., West E., Alemayehu W., Melese M., et al. Azithromycin post trichiasis surgery associated with reduction in recurrence in Ethiopia. Archives Ophthalmol. 2006; 124:309-314.
14. Emily W., Harran M., Beatriz M., et al. Risk factors for trichiasis recurrence in a Trachoma-endemic area. Invest. Ophthalmol. Vis. Sci. 2005; 46:447-453.
15. Congdon N., West S.K., Vitale S., et al. Exposure to children and risk of active trachoma in Tanzania women. Amer. ]. Epidemiol. 1993; 137:366-372.
16. Baggaley R., Solomon A., Kuper H., et al. Distance to water source and altitude in relation to active trachoma inRombo District, Tanzania. Trap. Med. Int. Hlth. 2006; 11:220-227.